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ABSTRACT A 1 2-kDa immunophilin (FKBP12)is an integral component of the skeletal muscle ryanodine receptor (RyR). The
RyR is a hetero-oligomeric complex with structural formula (FKBP)4(Ryrl)4, where Ryrl is the 565-kDa product of the Ryrl
gene. To aid in the detection of the immunophilin's location in the receptor, we exchanged the FKBP12 present in
RyR-enriched vesicles derived from sarcoplasmic reticulum with an engineered construct of FKBP12 fused to glutathione
S-transferase and then isolated the complexes. Cryoelectron microscopy and image averaging of the complexes (in an
orientation displaying the RyR's fourfold symmetry) revealed four symmetrically distributed, diffuse density regions that were
located just outside the boundary defining the cytoplasmic assembly of the RyR. These regions are attributed to the
glutathione transferase portion of the fusion protein because they are absent from receptors lacking the fusion protein. To
more precisely define the location of FKBP1 2, we similarly analyzed complexes of RyR containing FKBP1 2 itself. Apparently
some FKBP is lost during purification or storage of the RyR because, to detect the receptor-bound immunophilin, it was
necessary to add FKBP1 2 to the purified receptor before electron microscopy. Averaged images of these complexes showed
a region of density that had not been observed previously in images of isolated receptors, and its position, along the edges
of the transmembrane assembly, agreed with the position of the FKBP12 deduced from the experiments with the fusion
protein. The proposed locations for FKBP1 2 are about 10 nm from the transmembrane baseplate assembly that contains the
ion channel of the RyR.
INTRODUCTION
Immunophilins are intracellular proteins that were origi-
nally identified as receptors for drugs that inhibit the im-
mune response. Their cellular functions in the absence of
immunosuppressants are unclear, but they are thought to
serve as molecular chaperones that assist in protein folding
and assembly (reviewed in Fruman et al., 1994). Rutherford
and Zuker (1994) hypothesize that immunophilins also
function in cellular signal transduction pathways by forming
complexes with other macromolecules, thereby promoting
structural transitions that are required for signaling. A po-
tential example of this latter function is the stable complex
formed by the immunophilin, FK506-binding protein
(FKBP12), and the skeletal muscle ryanodine receptor pro-
tein (Collins, 1991; Jayaraman et al., 1992).
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The ryanodine receptor (RyR) is an intracellular calcium
release channel located on the junctional face membrane of
the terminal cistemae regions of the sarcoplasmic reticulum
in striated muscle. The receptor mediates release of Ca2'
from intracellular stores and hence plays a key role in
excitation-contraction coupling. Several studies have docu-
mented differences in channel activity of RyRs that contain
FKBP12 as compared with receptors depleted of it, but the
structural basis of these effects is unknown (Timerman et
al., 1993, 1995; Brillantes et al., 1994; Mayrleitner et al.,
1994; Chen et al., 1994; Ma et al., 1995).
Association of FK-506 binding proteins with intracellular
calcium channels appears to be of general significance as
the heart isoform of the RyR binds a protein similar to
FKBP12 (Timerman et al., 1994) and the inositol 1,4,5-
trisphosphate receptor (the other major intracellular calcium
release channel) from rat cerebellum binds FKBP12 (Cam-
eron et al., 1995).
We have been investigating the structure of the skeletal
muscle RyR by cryoelectron microscopy and three-dimen-
sional reconstruction (Wagenknecht et al., 1989, 1994; Ra-
dermacher et al., 1992, 1994; Wagenknecht and Raderma-
cher, 1995). This RyR comprises four copies each of a large
subunit (565 kDa) encoded by the Ryrl gene and FKBP12
(for reviews see Fleischer and Inui, 1989; Meissner, 1994;
Ogawa, 1994; Coronado et al., 1994). Here we show that
four symmetrically related binding sites for the FKBP12 are
present on the cytoplasmic assembly of the RyR. The sites
are along the edges of the square-shaped assembly, and 10
1 709
Volume 70 April 1996
FIGURE 1 Cryoelectron microscopy
and image averaging of RyRs containing
GST/FKBP12. (A) Electron micrograph
of frozen-hydrated GST/FKBP12:RyR
complexes. Arrowheads point to mass
densities, presumably due to the GST,
that are peripherally associated with
RyRs (which appear square in overall
shape). Bar, 100 nm. (B) Averaged image
(N = 371) of RyR:GST/FKBPl2 com-
plexes. +, density regions attributed to
GST; ?, potential regions where GSTs are
attached via FKBP12 to the RyR. The
region labeled 9 corresponds to a struc-
tural domain identified previously in
three-dimensional reconstructions of the
RyR (Radermacher et al., 1994). (C)
Control-averaged image of RyRs isolated
by standard protocol and described pre-
viously (Radermacher et al., 1994). (D)
Difference formed by subtracting aver-
aged image in C from that in B. (E) Same
as D, except that an outline of the control
average is shown superimposed on the
difference map. Width of each frame in
B-E is 68 nm.
or more nanometers from the putative entrance of the




FK590 (an analog of FK506 that is equally effective in displacing FKBP12
from the RyR), human FKBP12, and the GST/FKBP12 construct were
provided by Dr. G. Wiederrecht (Merck Research Laboratories, Rahway,
NJ). RyRs in which FKBP12 was replaced with GST/FKBP12 were
isolated as described by Xin et al. (1995). [3H]Ryanodine was from New
England Nuclear. CHAPS was from Calbiochem (La Jolla, CA).
Purification of RyR from rabbit skeletal muscle
RyRs were isolated from terminal cisternae vesicles of sarcoplasmic retic-
ulum (Saito et al., 1984) after solubilization in the presence of 4% CHAPS
(Inui et al., 1987). The solubilized receptor was purified by centrifugation
through sucrose density gradients (10-20% w/w) in a buffer consisting of
--------------- ----------
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FIGURE 2 Purified RyR binds exogenously added FKBP12. SDS-
PAGE of resuspended pellets resulting from centrifugation of the following
(see Materials and Methods): (Lane 1) RyR incubated with exogenous
FKBP12 in the presence of FK590. Note much reduced intensity of band
corresponding to FKBP12 (labeled FK at right side). (Lane 2) RyR incu-
bated with, excess FKBP12. (Lane 3) RyR alone. (Lane 4) RyR before
ultracentrifugation (2 ,ug). (Lane 5) FKBP12 (0.1 jig). For Lanes 1-3, a
volume of resuspended receptor corresponding to 2 jig of protein, assum-
ing 100% recovery in the pellets, was applied. Quantitative densitometry
indicated that the amount of protein in the band corresponding to the Ryrl
gene product (RyR on right side) in each of Lanes 1-4 was within 12% of
its mean value. The band of mobility intermediate to that of Ryrl and
FKBP12 is a contaminant, most likely the sarcoplasmic Ca2+-ATPase.
20 mM Tris-HCl (pH 7.4), 1.0 M NaCl, 2 mM dithiothreitol, 1 ,ug/ml
leupeptin, 1% (w/v) CHAPS, 0.5% (w/v) soy phosphatidyl choline, essentially
as described by Lai et al. (1988) and Timerman et al. (1993). The peak of
ryanodine binding activity was pooled and passed through a "desalting"
column (2.5 x 14 cm) containing Sephadex G25 (Pharmacia) and equilibrated
with buffer (20mM Tris-HCl (pH 7.4), 0.1 M NaCl, 2mM dithiothreitol, 0.5%
CHAPS, 0.5% phosphatidylcholine, 1 jig/ml leupeptin). The RyR was further
purified and concentrated by chromatography on a heparin agarose (Bio-Rad)
column (0.7 x 8 cm). The material eluted from the Sephadex G25 column was
applied to the heparin-agarose column, and elution was achieved with a buffer
containing 1.0 M NaCl (buffer I: 0.02 M Tris-HCl (pH 7.4), 1 M NaCl, 2 mM
dithiothreitol, 0.5% CHAPS, 1 ,ug/ml leupeptin).
Preparation and characterization of RyR with
exogenously added FKBP12 and FKBP12-
depleted RyR
Purified RyR in buffer I at 0.15 ,uM (0.035 mg/ml) was incubated at room
temperature for 60 min with FKBP12 at 4.4-4.7 ,iM in the absence or
presence of 50 ,AM FK590. Aliquots were removed to prepare grids for
cryoelectron microscopy (see below) or for analysis by sedimentation and
electrophoresis. For the latter purpose, 21 ,ul of sample was loaded into a
microcentrifuge tube (5 by 20 mm) containing a sucrose shelf (170 ,ul of
10% (w/w) sucrose in buffer I). The tubes were centrifuged for 4 h at
45,000 rpm and 4°C in a Beckman TLS-55 rotor using a Beckman Optima
TLX tabletop ultracentrifuge. The supernatants were removed by aspira-
tion, and the pellets were resuspended in sample buffer for SDS-PAGE
using the Laemmli (1970) buffer system.
Cryoelectron microscopy and image processing
Five-microliter portions of specimen containing RyR at 0.035 mg/ml were
applied to carbon-coated electron microscope grids and frozen by plunging
into cryogen (ethane). The grids were transferred to a Gatan model 626
cryo-holder, and electron microscopy was performed using a Philips
EM420 transmission electron microscope operated at 100 kV and a mag-
nification of 36,OOOX or 49,OOOX. The procedures were essentially iden-
tical to those described previously (Wagenknecht et al., 1994).
Image processing was done using the SPIDER software package (Frank
et al., 1981a) as described by Wagenknecht et al. (1994). For computing
averaged images, homogeneous sets of aligned RyR images were selected
by multivariate statistical analysis as described by Radermacher et al.
(1994). Fourfold symmetry was enforced in all of the averages shown; no
significant differences were apparent in the averages after symmetrization
other than the expected improvement in signal-to-noise ratio. Reproduc-
ibility of the averaged images was estimated by the 45-degree phase
residual criterion (Frank et al., 1981b). All of the averaged images shown
in Figs. 1 and 3 had resolutions in the range of 3-3.5 nm. SPIDER includes
programs to assess the statistical significance of differences between im-
ages (e.g., t-test; Frank et al., 1985). The differences that are attributed to
RyR-bound FKBP12 and GST/FKBP12 in this study are highly significant
(confidence limits greater than 99.9%).
RESULTS AND DISCUSSION
Our initial efforts to detect endogenous FKBP12 associated
with purified, CHAPS-solubilized RyRs by electron micros-
copy/image analysis were unsuccessful (results not shown).
In these experiments RyR was purified from terminal cis-
ternae vesicles that had either been treated or not been
treated with FK-590, a drug that has been shown to disso-
ciate FKBP12 from the RyR (Timerman et al., 1993). Quan-
titative comparison of electron micrographs obtained from
the two preparations failed to resolve any density differ-
ences attributable to FKBP12. Evidently, much of the
FKBP12 dissociated from the receptors during purification,
storage, or preparation for electron microscopy (see Fig. 2
and discussion thereof below), because RyRs in the terminal
cisternae (the starting material for the purification of recep-
tors) have 4 moles of bound FKBP per mole of receptor
(Timerman et al., 1993).
Two modified experimental approaches were devised to
redress the putative loss of FKBP12 from the receptor, the
results of which are described in the following sections. In
the first modification, RyRs were isolated from sarcoplas-
mic vesicles for which the endogenous FKBP12 was ex-
changed with a fusion protein (GST/FKBP12) consisting of
FKBP12 and glutathione transferase (Xin et al., 1995). The
rationale is that the larger fusion protein should be easier to
detect than FKBP12, even if levels of binding are substoi-
chiometric (i.e., less than 4 moles bound FKBP12 per mole
tetrameric RyR).
In the second modified protocol, we added excess exog-
enous FKBP12 to purified RyRs to fill any vacant binding
sites that might have been created during the isolation and
preparation for electron microsocopy. Electron micrograph
images of these RyRs were then quantitatively compared
with images from receptors that were treated with FK590 to
dissociate PKBP12.
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FIGURE 3 Cryoelectron microscopy
and image averaging of RyRs containing
exogenously added FKBP12 in the pres-
ence and absence of FK590. (A) Aver-
aged image of RyR incubated with exog-
enous FKBP12 (N = 632). (B) Averaged
image of RyR incubated with exogenous
FKBP12 and FK590 (N = 412). (C) Dif-
ference image obtained by subtracting B
from A. (D) difference image as in C, but
with oudline of control image in B super-
imposed. The four largest, symmetrically
arranged peaks, one of which is marked
with an arrowhead in A, C, and D, cor-
respond to mass present in A but not in B.
Domain 9 is also indicated in A, B, and
D. Width of each frame, 68 nm.
Cryoelectron microscopy/image analysis of RyRs
containing bound GST/FKBP12
Fig. 1 A shows selected images from an electron micrograph
of solubilized, frozen-hydrated RyRs isolated from SR-
derived vesicles containing the GST/FKBP12 fusion protein
in place of FKBP12. Biochemical and functional character-
ization of terminal cisternae vesicles has shown that the
endogenous FKBP12 readily undergoes competitive ex-
change with FKBP12 or various modified forms of it (Tim-
erman et al., 1995; Xin et al., 1995). The RyRs appear to be
morphologically intact for the most part and appear essen-
tially the same as RyRs obtained without the exchange of
GSTIFKBP12. Upon close inspection some of the com-
plexes appear to have some extra density outside the bound-
ary of the receptor (see marked receptors in the electron
micrograph shown in Fig. 1 A), but, because of the low
signal-to-noise ratio in the micrographs, it is necessary to
average images to establish the validity of the peripherally
localized densities. An averaged image, shown in Fig. 1 B,
clearly shows four symmetically distributed regions of den-
sity surrounding the RyR. We have never observed this
peripheral density in averages of RyRs isolated in the usual
manner (e.g., Fig. 1 C), and these regions are attributed to
the glutathione transferase portion of the fusion protein. The
size of the peripheral densities appears larger than expected
on the basis of the known three-dimensional structures of
glutathione transferases (Wilce and Parker, 1995); this
could be due to flexibility of the connection between the
GST and FKBP12, which would result in a smearing out of
the density. Alternatively, it is possible that the fusion
protein forms dimers via interactions among the GST do-
mains (Walker et al., 1993).
From the averaged image in Fig. 1 B it is difficult to
determine where the peripherally attached material is at-
tached to the RyR, which should correspond to the position
of the FKBP12. Weak bridges of density appear to extend to
the edge of the RyR at two locations (indicated by ? in Fig.
1 B), with the bridge extending toward the structural feature
labeled 9 (corresponding to domain 9 in the three-dimen-
sional reconstruction described by Radermacher et al.,
1994) appearing slightly more plausible because it is better
defined and the distance it traverses is shorter than the other
bridge. This is more clearly seen in the difference image,
obtained by subtracting the control average (Fig. 1 C) from
that of the GST/FKBP:RyR (Fig. 1 B), which shows, in
addition to the main differences due to the GST, subsidiary
regions of positive difference adjacent to domain 9 (Fig. 1,
D and E). Confirmation that the region adjacent to domain
9 is indeed the location of FKBP12 was obtained from the
experiments with exogenous FKBP12, described below.
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Analysis of RyRs with exogenously
added FKBP12
Purified RyRs were incubated with added FKBP12 at final
concentrations of 0.15 and 5 ,uM, respectively (see Materi-
als and Methods for details). A second incubation was done
identically, except that FK-590 was also present (50 ,uM) to
promote dissociation of FKBP12 from RyR. Evidence that
substantial binding of exogenously added FKBP12 occurred
in the absence ofFK590 was obtained by ultracentrifugation
of a portion of each incubation followed by SDS-PAGE of
the pellets (Fig. 2). Comparison of Lanes 2 (RyR in pres-
ence of exogenously added FKBP12) and 1 (RyR with
FK590 and FKBP12 added) shows significantly more
FKBP12 in Lane 2. Thus, the drug, FK590, was effective in
preventing complex formation and in dissociating endoge-
nous FKBP12 from the RyR. Lane 3, containing isolated
RyR that had not been treated with the drug or exogenous
FKBP12, shows a reduced level of (bound) FKBP12 rela-
tive to that when exogenous FKBP was present (Lane 2).
This indicates that isolated RyRs contain less than the
maximal amount FKBP12, and is consistent with our hy-
pothesis that some dissociation of FKBP12 occurs during
purification of the receptor. Purified RyR that was not
pelleted before electrophoresis (Lane 4) shows a higher
level of FKBP12 than the pelleted receptor (Lane 3), indicat-
ing that some of the FKBP12 in the purified receptor is not
bound or is not bound with sufficient affinity to cosediment
quantitatively with the RyR.
Averaged images obtained from electron micrographs
of frozen-hydrated RyRs that had been incubated with
exogenous FKBP12 in the absence and presence of
FK590 are shown in Fig. 3, A and B, respectively. The
average of the receptors that were not treated with the
drug shows an additional density protruding from each of
the receptor's edges (arrowheads in the figure) that is not
present in the drug-treated average. This extra density
dominates the difference image (Fig. 3 C) formed by
subtracting the average in Fig. 3 B from that in Fig. 3 A,
and, therefore, likely corresponds to receptor-bound
FKBP12. The positions of the differences attributed to
FKBP12 are near subdomain 9 of the RyR, in agreement
with the position inferred from the experiment with the
GST/FKBP12 fusion protein (Fig. 1). Furthermore, its
apparent diameter, -3 nm, is consistent with the known
three-dimensional structure of FKBP12 (Moore et al.,
1991; van Duyne et al., 1991). It seems unlikely that the
FIGURE 4 Three-dimensional model of RyR from Radermacher et al.
(1994) showing locations of FKBP12. (A) Solid-body representation per-
pendicular to fourfold symmetry axis (side view) with transmembrane
assembly at bottom. The rectangle indicates range of potential positions for
FKBP12. (B) View along fourfold axis showing face of cytoplasmic
assembly that faces the transverse tubule in situ. (C) View along fourfold
axis onto sarcoplasmic face that contains the transmembrane assembly
(center). Asterisk indicates likely location of entrance to transmembrane
ion-conducting channel; +, location of density differences as defined in
Fig. 3; numerals refer to domains as assigned in Radermacher et al. (1994).
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density assigned to FKBP12 in Fig. 3 is due to binding of
the immunophilin to a secondary site that differs from the
site occupied in isolated sarcoplasmic vesicles. First, no
other differences of magnitude comparable to that as-
signed to FKBP12 are present in the difference map. If
the exogenously added FKBP12 resulted in occupation of
a secondary site, then eight peaks should have been
present in the difference image instead of four. Second,
the binding of exogenous FKBP12 is prevented by FK-
590, which is the same behavior as for sarcoplasmic
vesicles. Third, the proposed location for receptor-bound
FKBP12 is consistent with the results of the experiment
using GST/FKBP12 (Fig. 1). In that experiment the
FKBP12 was replaced by GST/FKBP12 on RyRs that
were associated with terminal cisternae, and then the
receptors were isolated by affinity chromatography-no
exogenous, excess GST/FKBP12 was added to the solu-
bilized, purified receptor. Characterization of FKBP12
exchange on terminal cisternae has shown that exchange
occurs by competition with endogenous FKBP12 for the
same binding sites and with retention of native function
(Mayrleitner et al., 1994; Timerman et al., 1995).
In this study we have localized the binding of FKBP12 in
two dimensions to a position that is along the edges of the
RyR's transmembrane assembly. A three-dimensional re-
construction, currently in progress, will be required to pre-
cisely define the location of the bound FKBP12 in the third
dimension and to characterize any structural changes that
occur when FKBP12 is removed. In the interim, we show in
Fig. 4 the range of possible positions for FKBP12 on the
three-dimensional reconstruction of the RyR that was de-
scribed previously (Radermacher et al., 1994). Note that the
uncertainty in the indeterminate ("z") direction can be no
greater than 60-70 A (Fig. 4 A), the thickness of the RyR in
this direction. FKBP12 binds on the RyR on domain 3,
which forms the sides of the cytoplasmic assembly, near
domain 9. Four symmetry-related binding positions are
present on the RyR, which is consistent with binding data
indicating four binding sites per tetrameric RyR (Timerman
et al., 1993, 1995). The FKBP12 binding sites are about 10
nm from the center of the averaged image (Fig. 3 C), the
presumed location of the ion channel. The actual distance
could be several nanometers greater than this, depending on
the z-coordinate of the binding site.
FKBP12 is the second RyR-modulating protein ligand
that has been mapped to a peripheral binding location on the
cytoplasmic assembly of the receptor (Wagenknecht et al.,
1994). The other ligand is calmodulin, which binds on the
opposite side of domain 3 from that where FKBP12 binds,
(Fig. 4 A) (binding studies indicate that additional calmod-
ulin sites are present under other experimental conditions;
Yang et al., 1994; Tripathy et al., 1995). Both FKBP12 and
calmodulin affect the ion channel activity of the RyR, and
our results argue for the involvement of long-range struc-
tural changes in the RyR because both ligands bind at large
distances from the putative location of the ion-conducting
channel in the transmembrane assembly.
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